Venous Thromboembolism (VTE) Knowledge

计划入组 200 人 · 首次发布于 2022 年 9 月 21 日

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

计划入组 920 人 · 首次发布于 2025 年 5 月 4 日

Exercise Training After an Acute Blood Clot

计划入组 20 人 · 首次发布于 2013 年 5 月 29 日

VCE-002

VTC-G90

VTC-G15

ENDOFOTONICS PTE. LTD.

Singapore

SciGen Pte Ltd.

Singapore

STERISCIENCE PTE. LIMITED

Singapore

Extended Low-Dose Apixaban Cuts Recurrent VTE in High-Risk Provoked Patients

Extended Low-Dose Apixaban Reduces VTE Recurrence by 87% in High-Risk Patients

Low-Dose Apixaban Proves Effective and Safer for Extended Cancer-Related VTE Prevention